BioInformant

Your Global Leader in Stem Cell Market Research

Home » strategy » Page 2

Need Results for Your Stem Cell Company or Cord Blood Bank? BioInformant Shares Testimonials

By Leave a Comment

Competing in the Stem Cell Marketplace is a Difficult Task

For executives operating a stem cell company or cord blood bank, competing in the marketplace is a difficult task.  You must analyze market conditions, predict industry trends, and capitalize on market changes before the competition. Especially within the rapidly evolving stem cell marketplace, it can be difficult to make educated, informed decisions that produce revenue growth for your company, while limiting failed products that won’t have demand in the marketplace. [Read more…]

MarketResearch.com: “Blockbuster” Year for Stem Cells Creates Market Opportunities

By Leave a Comment

PRESS RELEASE

WASHINGTON and NEW YORK CITY and LONDON, April 1, 2015 /PRNewswire/ — As a leading provider of market research reports and solutions, MarketResearch.com is pleased to highlight a report by BioInformant Worldwide, LLC, indicating that 2015 will be a year of market growth and opportunity for the stem cell industry.

For executives operating a stem cell company or cord blood bank, competing in the stem cell marketplace is a difficult task. You must analyze market conditions, predict industry trends, and act on market changes before the competition. [Read more…]

BIOINFORMANT’S MISSION: To be OMNIPRESENT in the Stem Cell and Cord Blood Marketplace

By Leave a Comment

You Deserve Transparency

Some companies will not share their mission with you. They think it is top-secret information, private to them, something they have to hold under close guard.

This doesn’t make any sense.  We want you to have a clear understanding of our mission, because we want to serve you, partner with you, and most importantly, be fully transparent with you.

Therefore, here is BioInformant’s mission for 2015…

To be OMNIPRESENT in the stem cell and cord blood banking marketplace.

Educating You About the Stem Cell Space
Educating you about stem cell and cord blood markets, so you can make smarter decisions, faster.

[Read more…]

Tasked with Meeting Increasingly Large Sales Goals for Your Stem Cell Company?

By Leave a Comment

This was a major year for stem cells, as we saw the first ever induced pluripotent stem cell (iPSC) trial in humans, as well as several large mergers and acquisitions within the stem cell industry. One of the most prominent was the buyout of Life Technologies by industry behemoth Thermo Fisher Scientific.

There were also major technical advances that occurred, including notable advances made by scientists at the Harvard Stem Cell Institute (HSCI) toward the creation of human insulin-producing cells from human embryonic stem cells, as well as advances in the bio-fabrication of human tissues using 3-D cell printing technology, led by Guohao Dai of the Rensselaer Polytechnic Institute, among others.
[Read more…]

BioInformant's World-Class Clients